Homoeopathic treatment of a diabetic COVID-19 patient with the complication of bronchitis and pleural effusion - A case report

Q3 Medicine

Indian Journal of Research in Homoeopathy Pub Date : 2022-12-27 DOI:10.53945/2320-7094.1180

A. Ghosh, Sadia Kamal

{"title":"Homoeopathic treatment of a diabetic COVID-19 patient with the complication of bronchitis and pleural effusion - A case report","authors":"A. Ghosh, Sadia Kamal","doi":"10.53945/2320-7094.1180","DOIUrl":null,"url":null,"abstract":"Introduction: COVID-19 is a novel SARS-CoV-2 disease that has caused a worldwide pandemic. It is highly contagious and produces severe acute respiratory syndrome. Many homoeopathic medicines have been suggested for treatment of COVID cases and reports have also been published. Case Summary: The present case report is of a 61-year-old COVID-positive, male, presenting with complications such as bronchitis and pleural effusion. He was treated for COVID-19 with a suitable homoeopathic medicine, based on the totality of symptoms, while the patient continued his regular regime of conventional medicine for diabetes mellitus and hypertension. The indicated remedy led to immediate relief of the symptoms, especially chest pain, along with a marked improvement in the laboratory investigations. The Modified Naranjo Criteria score after treatment was 8, which explicitly shows the positive causal attribution of the individualised homoeopathic medicine, Phosphorus, in this case. Homoeopathic treatment has shown favourable results in this case and demonstrates the scope of Homoeopathy in infectious cases. Acknowledgments and Source of Funding This case report is available in Indian Journal of Research in Homoeopathy: https://www.ijrh.org/journal/vol16/iss4/6 © 2022 Indian Journal of Research in Homoeopathy | Hosted online by Digital Commons (Bepress) 301 Abstract Case Report","PeriodicalId":13469,"journal":{"name":"Indian Journal of Research in Homoeopathy","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Research in Homoeopathy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53945/2320-7094.1180","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 1

Abstract

Introduction: COVID-19 is a novel SARS-CoV-2 disease that has caused a worldwide pandemic. It is highly contagious and produces severe acute respiratory syndrome. Many homoeopathic medicines have been suggested for treatment of COVID cases and reports have also been published. Case Summary: The present case report is of a 61-year-old COVID-positive, male, presenting with complications such as bronchitis and pleural effusion. He was treated for COVID-19 with a suitable homoeopathic medicine, based on the totality of symptoms, while the patient continued his regular regime of conventional medicine for diabetes mellitus and hypertension. The indicated remedy led to immediate relief of the symptoms, especially chest pain, along with a marked improvement in the laboratory investigations. The Modified Naranjo Criteria score after treatment was 8, which explicitly shows the positive causal attribution of the individualised homoeopathic medicine, Phosphorus, in this case. Homoeopathic treatment has shown favourable results in this case and demonstrates the scope of Homoeopathy in infectious cases. Acknowledgments and Source of Funding This case report is available in Indian Journal of Research in Homoeopathy: https://www.ijrh.org/journal/vol16/iss4/6 © 2022 Indian Journal of Research in Homoeopathy | Hosted online by Digital Commons (Bepress) 301 Abstract Case Report

查看原文本刊更多论文

一例糖尿病新冠肺炎合并支气管炎和胸腔积液患者的顺势疗法治疗报告

简介：新冠肺炎是一种新型的严重急性呼吸系统综合征冠状病毒2型疾病，已引起全球大流行。它具有高度传染性，会产生严重的急性呼吸系统综合征。许多顺势疗法药物已被建议用于治疗新冠肺炎病例，报告也已发表。病例总结：本病例报告为一名61岁的新冠肺炎阳性患者，男性，伴有支气管炎和胸腔积液等并发症。根据所有症状，他接受了新冠肺炎的治疗，并服用了合适的顺势疗法药物，同时患者继续接受糖尿病和高血压的常规常规药物治疗。指定的治疗方法立即缓解了症状，尤其是胸痛，实验室调查也有了显著改善。治疗后的改良Naranjo标准评分为8分，明确显示了本例中个性化顺势疗法药物磷的积极因果归因。顺势疗法在本病例中显示出良好的效果，并证明了顺势疗法在感染病例中的作用范围。致谢和资金来源本病例报告可在《印度顺势疗法研究杂志》上查阅：https://www.ijrh.org/journal/vol16/iss4/6©2022《印度同性恋研究杂志》|由Digital Commons在线主办（Bepress）301摘要病例报告

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊